Micron Technology (Nasdaq: MU) $32.19. Baird upgraded Micron from Neutral to Outperform and moved its price target from $25 up to $42. Shares of Micron rose 3.3 percent.
bluebird bio, Inc. (Nasdaq: BLUE) $41.77. bluebird bio released initial positive clinical data from its HGB-205 clinical study of its LentiGlobin BB305 product candidate in beta-thalassemia major subjects at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy. Shares rose just over 60 percent to the new high today.
